Your browser doesn't support javascript.
loading
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey.
Roope, Laurence S J; Buchanan, James; Morrell, Liz; Pouwels, Koen B; Sivyer, Katy; Mowbray, Fiona; Abel, Lucy; Cross, Elizabeth L A; Yardley, Lucy; Peto, Tim; Walker, A Sarah; Llewelyn, Martin J; Wordsworth, Sarah.
Afiliação
  • Roope LSJ; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK. laurence.roope@dph.ox.ac.uk.
  • Buchanan J; NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK. laurence.roope@dph.ox.ac.uk.
  • Morrell L; NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England (PHE), Oxford, UK. laurence.roope@dph.ox.ac.uk.
  • Pouwels KB; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK.
  • Sivyer K; NIHR Oxford Biomedical Research Centre, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Mowbray F; NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England (PHE), Oxford, UK.
  • Abel L; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK.
  • Cross ELA; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, OX3 7LF, UK.
  • Yardley L; NIHR Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford in partnership with Public Health England (PHE), Oxford, UK.
  • Peto T; Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
  • Walker AS; Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.
  • Llewelyn MJ; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
  • Wordsworth S; Department of Microbiology and Infection, Brighton and Sussex University Hospitals NHS Trust, Eastern Road, Brighton, UK.
BMC Med ; 18(1): 196, 2020 07 30.
Article em En | MEDLINE | ID: mdl-32727604
BACKGROUND: Deciding whether to discontinue antibiotics at early review is a cornerstone of hospital antimicrobial stewardship practice worldwide. In England, this approach is described in government guidance ('Start Smart then Focus'). However, < 10% of hospital antibiotic prescriptions are discontinued at review, despite evidence that 20-30% could be discontinued safely. We aimed to quantify the relative importance of factors influencing prescriber decision-making at review. METHODS: We conducted an online choice experiment, a survey method to elicit preferences. Acute/general hospital prescribers in England were asked if they would continue or discontinue antibiotic treatment in 15 hypothetical scenarios. Scenarios were described according to six attributes, including patients' presenting symptoms and whether discontinuation would conflict with local prescribing guidelines. Respondents' choices were analysed using conditional logistic regression. RESULTS: One hundred respondents completed the survey. Respondents were more likely to continue antibiotics when discontinuation would 'strongly conflict' with local guidelines (average marginal effect (AME) on the probability of continuing + 0.194 (p < 0.001)), when presenting symptoms more clearly indicated antibiotics (AME of urinary tract infection symptoms + 0.173 (p < 0.001) versus unclear symptoms) and when patients had severe frailty/comorbidities (AME = + 0.101 (p < 0.001)). Respondents were less likely to continue antibiotics when under no external pressure to continue (AME = - 0.101 (p < 0.001)). Decisions were also influenced by the risks to patient health of continuing/discontinuing antibiotic treatment. CONCLUSIONS: Guidelines that conflict with antibiotic discontinuation (e.g. pre-specify fixed durations) may discourage safe discontinuation at review. In contrast, guidelines conditional on patient factors/treatment response could help hospital prescribers discontinue antibiotics if diagnostic information suggesting they are no longer needed is available.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antibacterianos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antibacterianos Tipo de estudo: Guideline / Prognostic_studies / Qualitative_research Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Med Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article